Literature DB >> 21945581

Multiplex IP-FCM (immunoprecipitation-flow cytometry): Principles and guidelines for assessing physiologic protein-protein interactions in multiprotein complexes.

Anya T Bida1, Diana Gil, Adam G Schrum.   

Abstract

There is significant interest in the development of methods with the potential to increase access to 'the interactome' for both experimental and clinical applications. Immunoprecipitation detected by flow cytometry (IP-FCM) is a robust, biochemical method that can be used for measuring physiologic protein-protein interactions (PPI) in multiprotein complexes (MPC) with high sensitivity. Because it is based on antibody-mediated capture of protein complexes onto microspheres, IP-FCM is potentially compatible with a multiplex platform that could allow simultaneous assessment of many physiologic PPI. Here, we consider the principles of ambient analyte conditions (AAC) and inter-bead independence, and provide a template set of experiments showing how to convert singleplex IP-FCM to multiplex IP-FCM, including assays to confirm the validity of the experimental conditions for data acquisition. We conclude that singleplex IP-FCM can be successfully upgraded to multiplex format, and propose that the unique strengths of multiplex IP-FCM make it a method that is likely to facilitate the acquisition of new PPI data from primary cell sources. Copyright Â
© 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21945581      PMCID: PMC3261325          DOI: 10.1016/j.ymeth.2011.09.005

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  27 in total

1.  High-sensitivity detection and quantitative analysis of native protein-protein interactions and multiprotein complexes by flow cytometry.

Authors:  Adam G Schrum; Diana Gil; Elaine P Dopfer; David L Wiest; Laurence A Turka; Wolfgang W A Schamel; Ed Palmer
Journal:  Sci STKE       Date:  2007-06-05

Review 2.  Detecting and interfering protein interactions: towards the control of biochemical pathways.

Authors:  Montse Morell; Francesc X Avilés; Salvador Ventura
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

3.  Development of a flow cytometric co-immunoprecipitation technique for the study of multiple protein-protein interactions and its application to T-cell receptor analysis.

Authors:  John S Bridgeman; Morgan Blaylock; Robert E Hawkins; David E Gilham
Journal:  Cytometry A       Date:  2010-04       Impact factor: 4.355

4.  Microsphere-based co-immunoprecipitation in multiplex.

Authors:  Oliver Poetz; Katrin Luckert; Thomas Herget; Thomas O Joos
Journal:  Anal Biochem       Date:  2009-08-07       Impact factor: 3.365

5.  Mechanism of T cell tolerance induced by myeloid-derived suppressor cells.

Authors:  Srinivas Nagaraj; Adam G Schrum; Hyun-Il Cho; Esteban Celis; Dmitry I Gabrilovich
Journal:  J Immunol       Date:  2010-02-08       Impact factor: 5.422

6.  Multiplex analysis of serum cytokines in melanoma patients treated with interferon-alpha2b.

Authors:  Zoya R Yurkovetsky; John M Kirkwood; Howard D Edington; Adele M Marrangoni; Lyudmila Velikokhatnaya; Matthew T Winans; Elieser Gorelik; Anna E Lokshin
Journal:  Clin Cancer Res       Date:  2007-04-15       Impact factor: 12.531

7.  Polyplexed flow cytometry protein interaction assay: a novel high-throughput screening paradigm for RGS protein inhibitors.

Authors:  David L Roman; Shodai Ota; Richard R Neubig
Journal:  J Biomol Screen       Date:  2009-06-16

Review 8.  T cell activation.

Authors:  Jennifer E Smith-Garvin; Gary A Koretzky; Martha S Jordan
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

9.  Use of flow cytometric methods to quantify protein-protein interactions.

Authors:  Levi L Blazer; David L Roman; Molly R Muxlow; Richard R Neubig
Journal:  Curr Protoc Cytom       Date:  2010-01

10.  Visualization of multiprotein complexes by flow cytometry.

Authors:  Adam G Schrum
Journal:  Curr Protoc Immunol       Date:  2009-11
View more
  7 in total

1.  KCa1.1 channels regulate β1-integrin function and cell adhesion in rheumatoid arthritis fibroblast-like synoviocytes.

Authors:  Mark R Tanner; Michael W Pennington; Teresina Laragione; Pércio S Gulko; Christine Beeton
Journal:  FASEB J       Date:  2017-04-20       Impact factor: 5.191

2.  Multiplex matrix network analysis of protein complexes in the human TCR signalosome.

Authors:  Stephen E P Smith; Steven C Neier; Brendan K Reed; Tessa R Davis; Jason P Sinnwell; Jeanette E Eckel-Passow; Gabriel F Sciallis; Carilyn N Wieland; Rochelle R Torgerson; Diana Gil; Claudia Neuhauser; Adam G Schrum
Journal:  Sci Signal       Date:  2016-08-02       Impact factor: 8.192

3.  Toward T cell protein-protein interaction activity relevant to alopecia areata.

Authors:  Steven C Neier; Stephen E P Smith; Tessa R Davis; Diana Gil; Adam G Schrum
Journal:  J Investig Dermatol Symp Proc       Date:  2013-12

4.  Signalling protein complexes isolated from primary human skin-resident T cells can be analysed by Multiplex IP-FCM.

Authors:  Stephen E P Smith; Steven C Neier; Tessa R Davis; Mark R Pittelkow; Diana Gil; Adam G Schrum
Journal:  Exp Dermatol       Date:  2014-04       Impact factor: 3.960

5.  IP-FCM measures physiologic protein-protein interactions modulated by signal transduction and small-molecule drug inhibition.

Authors:  Stephen E P Smith; Anya T Bida; Tessa R Davis; Hugues Sicotte; Steven E Patterson; Diana Gil; Adam G Schrum
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

6.  The tyrosine phosphorylated pro-survival form of Fas intensifies the EGF-induced signal in colorectal cancer cells through the nuclear EGFR/STAT3-mediated pathway.

Authors:  Ngoc Ly Ta; Krittalak Chakrabandhu; Sébastien Huault; Anne-Odile Hueber
Journal:  Sci Rep       Date:  2018-08-20       Impact factor: 4.379

7.  Robustness and Specificity in Signal Transduction via Physiologic Protein Interaction Networks.

Authors:  Adam G Schrum; Diana Gil
Journal:  Clin Exp Pharmacol       Date:  2012-12-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.